Emma Andersson - Concepedia

Author

Emma Andersson

Also Known As

Andersson, Emma, E Andersson, E I Andersson, E. Andersson, E. I. Andersson, Emma Andersson, Emma I Andersson, Emma I. Andersson, Emma Irene Andersson

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital Institute for Molecular Medicine Finland University of Cologne Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases

About

Emma Andersson is an author at University of Helsinki specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	707
2	Cell Biology	3	3	185
3	Engineering	1	1	95
4	Health Sciences	1	1	25
5	Biomolecular Engineering	1	1	95

Emma Andersson

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Somatic <i>STAT3</i> Mutations in Large Granular Lymphocytic Leukemia Hanna Koskela, Samuli Eldfors, Pekka Ellonen, New England Journal of Medicine	2012	752
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 Artur Schmidtchen, Inga‐Maria Frick, Emma Andersson, Molecular Microbiology Microbial PathogensInnate Immune SystemBacteriologyImmunologyOther Pathogens	2002	427
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia Hanna Rajala, Samuli Eldfors, Heikki Kuusanmäki, Blood	2013	291
Antimicrobial activities of heparin‐binding peptides Emma Andersson, Victoria Rydengård, Andreas Sonesson, European Journal of Biochemistry	2004	186
Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin Ole E. Sørensen, Lone Gram, Anders H. Johnsen, Journal of Biological Chemistry	2003	165
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target Olli Dufva, Matti Kankainen, Tiina Kelkka, Nature Communications	2018	139
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis Paula Savola, Tiina Kelkka, Hanna Rajala, Nature Communications	2017	118
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL Alexandra Schrader, Giuliano Crispatzu, Sebastian Oberbeck, Nature Communications	2018	101
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia Hanna Rajala, Thomas L. Olson, Michael J. Clemente, Haematologica Mixed-phenotype Acute LeukemiaImmunologyPathologyStat3 MutationsImmunotherapy	2014	97
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling Emma Andersson, S. Pützer, Bhagwan Yadav, Leukemia Novel Drug SensitivitiesPharmaceutical ResearchDrug TargetSignal TransductionEngineering	2017	95

Page 1